Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity.
about
Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic targetActivation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.Systemic Inhibition of CREB is Well-tolerated in vivo.Design, synthesis and biological evaluation of regioisomers of 666-15 as inhibitors of CREB-mediated gene transcription.Towards Targeting PI3K-Dependent Regulation of Gene Expression in Brain CancerAngiopoietin-like 4 Mediates Colonic Inflammation by Regulating Chemokine Transcript Stability via Tristetraprolin.GPR68, a proton-sensing GPCR, mediates interaction of cancer associated fibroblasts and cancer cells.Linking CREB function with altered metabolism in murine fibroblast-based model cell lines.The high-production volume fungicide pyraclostrobin induces triglyceride accumulation associated with mitochondrial dysfunction, and promotes adipocyte differentiation independent of PPARγ activation, in 3T3-L1 cells.Anticancer Pyrroloquinazoline LBL1 Targets Nuclear Lamins.Design, synthesis and evaluation of antitumor acylated monoaminopyrroloquinazolines.ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231.PI3K Activation in Neural Stem Cells Drives Tumorigenesis which can be Ameliorated by Targeting the cAMP Response Element Binding (CREB) Protein.A Lamin-Binding Ligand Inhibits Homologous Recombination Repair of DNA Double-Strand BreaksPresenilin 1 deficiency suppresses autophagy in human neural stem cells through reducing γ-secretase-independent ERK/CREB signalingTolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53
P2860
Q28070887-005ABB45-5632-4B8E-BA0A-072106BB63EAQ36862527-9FFDA082-40CF-4084-A082-326EDF3D6835Q37303415-274B65DD-B43A-4A46-BD35-247A37017F1EQ38722053-FE062455-5711-47D3-A295-4E083DE1ADB1Q39337955-B6B0AD65-80D6-4E3D-8590-7BEA89F62044Q42316912-A8442556-1873-4A67-885D-F5A24E3E7049Q46218367-7C7360FD-9852-488D-8691-B85D2E8CE334Q47306639-A7B1A3EB-283B-4A87-A46B-2BADB168AB21Q47415130-509CC671-F93D-4BB3-B02B-332ACB217B07Q52592110-016B9AEB-2C2A-43DC-ACE9-9727C3B43EC4Q53489936-73371B50-89FD-43CC-96EF-840839CA3873Q55315341-5C7DF385-2F2E-47BD-A0CE-A21E3DE7585DQ55457210-B1EE93B4-1120-4886-B909-60FFEC7A691DQ57068930-C3EFCFC1-D3AD-40DA-B4DC-B537C0F2FD02Q58695656-AD6D1C96-BA4A-47E8-B282-449EEE4B1B86Q58699629-E4CEF611-0807-432D-87E6-038D57F0EDF1
P2860
Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of a Potent Inh ...... s in Vivo Anticancer Activity.
@ast
Identification of a Potent Inh ...... s in Vivo Anticancer Activity.
@en
type
label
Identification of a Potent Inh ...... s in Vivo Anticancer Activity.
@ast
Identification of a Potent Inh ...... s in Vivo Anticancer Activity.
@en
prefLabel
Identification of a Potent Inh ...... s in Vivo Anticancer Activity.
@ast
Identification of a Potent Inh ...... s in Vivo Anticancer Activity.
@en
P2093
P2860
P1476
Identification of a Potent Inh ...... s in Vivo Anticancer Activity.
@en
P2093
Alina Kassenbrock
Bingbing X Li
Changhui Xue
David Z Qian
Fuchun Xie
Rosalie C Sears
Xiangshu Xiao
Xiaoyan Wang
P2860
P304
P356
10.1021/ACS.JMEDCHEM.5B00468
P407
P577
2015-06-05T00:00:00Z